pyrimidin-2-one beta-ribofuranoside has been researched along with Carcinoma, Anaplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byun, HM; Chuang, JC; Dubeau, L; Egger, G; Jones, PA; Laird, PW; Long, T; Marquez, VE; Yang, AS; Yoo, CB | 1 |
| Chan, JY; Ho, WK; Man, OY; To, VS; Tsang, CM; Tsang, RK; Tsao, SW; Wei, WI; Wong, TS | 1 |
2 other study(ies) available for pyrimidin-2-one beta-ribofuranoside and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Long-term epigenetic therapy with oral zebularine has minimal side effects and prevents intestinal tumors in mice.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Carcinoma; Cytidine; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Profiling; Genes, APC; Intestinal Mucosa; Intestinal Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Oligonucleotide Array Sequence Analysis; Organ Specificity; Sex Characteristics; Time Factors | 2008 |
MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.
Topics: Azacitidine; Carcinoma; Cell Growth Processes; Cell Line, Tumor; Cytidine; DNA Methylation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Proto-Oncogene Proteins c-myc; Transfection; Up-Regulation | 2011 |